NCT00082485View on ClinicalTrials.gov

Baclofen for the Treatment of Cocaine Dependence - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2006

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Baclofen

Dose escalation 10-60mg (week 1) 60 mg (weeks 2-7) Dose taper (week 8)

OTHER

Placebo

Placebo

Trial Locations (8)

21201

VA Maryland Healthcare System, Baltimore

80220

Denver VA Medical Center, Denver

84148

Salt Lake City VA Medical Center, Salt Lake City

90502

Torrance Site, Torrance

94110

San Francisco General Hosptial, San Francisco

19104 6178

U of Penn School of Medicine, Philadelphia

78284 4404

South TX VA Health Care System, San Antonio

22042 3300

Institute of Resch & Educ Inova Fairfax Hospital, Falls Church

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00082485 - Baclofen for the Treatment of Cocaine Dependence - 1 | Biotech Hunter | Biotech Hunter